The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on photodynamic therapy for localised inoperable endobronchial cancer.
Photodynamic therapy is a minimally invasive treatment, involving injection of a photosensitising agent, followed a few days later by photo-radiation to the affected area through a bronchoscope. This is intended to reduce the bulk of the tumour, thus reducing symptoms caused by bronchial obstruction. PDT is performed endobronchially, with debridement of necrotic tumour within a few days of each treatment.
E48.7 Fibreoptic endoscopic photodynamic therapy of lesion of lower respiratory tract
Chapter ‘Z’ code for site in lower respiratory tract
In addition an ICD-10 code from category C34.- Malignant neoplasm of bronchus and lung or C78.0 Secondary malignant neoplasm of lung is assigned.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding